Identification of potentially potent Heme Oxygenase-1 inhibitors through 3D-QSAR coupled to scaffold hopping analysis. (Q52564046)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

title

Identification of Potentially Potent Heme Oxygenase 1 Inhibitors through 3D-QSAR Coupled to Scaffold-Hopping Analysis (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Emanuele Amata

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Agostino Marrazzo

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Loredana Salerno

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Orazio Prezzavento

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Valeria Pittalà

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Antonio Rescifina

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

author name string

Maria Dichiara

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

Giuseppe Romeo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

publication date

29 May 2018

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

volume

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

issue

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

page(s)

1336-1342

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

Pharmacological and clinical aspects of heme oxygenase

24 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Recent insights into the biological functions of liver fatty acid binding protein 1

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Adipocyte fatty acid binding protein 4 (FABP4) inhibitors. A comprehensive systematic review.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Role of the Nrf2/HO-1 axis in bronchopulmonary dysplasia and hyperoxic lung injuries.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Nrf2 as regulator of innate immunity: A molecular Swiss army knife!

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Effects of Novel Nitric Oxide-Releasing Molecules against Oxidative Stress on Retinal Pigmented Epithelial Cells

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Novel Caffeic Acid Phenethyl Ester (Cape) Analogues as Inducers of Heme Oxygenase-1.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Effects of Polyphenolic Derivatives on Heme Oxygenase-System in Metabolic Dysfunctions.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme oxygenase-1 nuclear translocation regulates bortezomibinduced cytotoxicity and mediates genomic instability in myeloma cells

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Evaluation of novel aryloxyalkyl derivatives of imidazole and 1,2,4-triazole as heme oxygenase-1 (HO-1) inhibitors and their antitumor properties.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme oxygenase-1: A new druggable target in the management of chronic and acute myeloid leukemia.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme oxygenase-1 and its metabolites affect pancreatic tumor growth in vivo

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Recent advances in drug discovery of phototherapeutic non-porphyrinic anticancer agents.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

The Nrf2/HO-1 Axis in Cancer Cell Growth and Chemoresistance

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Novel imidazole derivatives as heme oxygenase-1 (HO-1) and heme oxygenase-2 (HO-2) inhibitors and their cytotoxic activity in human-derived cancer cell lines.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Synthesis and biological evaluation of phosphonated carbocyclic 2'-oxa-3'-aza-nucleosides

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme Oxygenase Database (HemeOxDB) and QSAR Analysis of Isoform 1 Inhibitors.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Comprehensive data on a 2D-QSAR model for Heme Oxygenase isoform 1 inhibitors

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Hyphenated 3D-QSAR statistical model-scaffold hopping analysis for the identification of potentially potent and selective sigma-2 receptor ligands

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

S2RSLDB: a comprehensive manually curated, internet-accessible database of the sigma-2 receptor selective ligands

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Development of a Sigma-2 Receptor affinity filter through a Monte Carlo based QSAR analysis.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Sigma-2 receptor ligands QSAR model dataset

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Comparative Molecular Field Analysis (CoMFA) and Comparative Molecular Similarity Indices Analysis (CoMSIA) studies on α(1A)-adrenergic receptor antagonists based on pharmacophore molecular alignment

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

3D-QSAR and 3D-QSSR studies of thieno[2,3-d]pyrimidin-4-yl hydrazone analogues as CDK4 inhibitors by CoMFA analysis

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

3D-QSAR studies on Maslinic acid analogs for Anticancer activity against Breast Cancer cell line MCF-7

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Development of Small-Molecule Cryptochrome Stabilizer Derivatives as Modulators of the Circadian Clock.

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

SIMPLS: An alternative approach to partial least squares regression

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

PLS-regression: a basic tool of chemometrics

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

https://api.crossref.org/works/10.1002/CMDC.201800176

1 reference

7 January 2021

https://api.crossref.org/works/10.1002/CMDC.201800176

1 reference

7 January 2021

Three-dimensional quantitative similarity-activity relationships (3D QSiAR) from SEAL similarity matrices

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Bioisosterism: A Rational Approach in Drug Design

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

ZINC--a free database of commercially available compounds for virtual screening

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

The ChEMBL bioactivity database: an update

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme oxygenase inhibition by 2-oxy-substituted 1-(1H-imidazol-1-yl)-4-phenylbutanes: effect of halogen substitution in the phenyl ring

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Structural insights into human heme oxygenase-1 inhibition by potent and selective azole-based compounds

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Optimization of parameters for semiempirical methods IV: extension of MNDO, AM1, and PM3 to more main group elements

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Suitability of the PM3-derived molecular electrostatic potentials

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Molecular field extrema as descriptors of biological activity: definition and validation

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Exploring the impact of size of training sets for the development of predictive QSAR models

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

X-ray crystallographic and biochemical characterization of the inhibitory action of an imidazole-dioxolane compound on heme oxygenase

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

X-ray crystal structure of human heme oxygenase-1 in complex with 1-(adamantan-1-yl)-2-(1H-imidazol-1-yl)ethanone: a common binding mode for imidazole-based heme oxygenase-1 inhibitors

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

X-ray crystal structure of human heme oxygenase-1 with (2R,4S)-2-[2-(4-chlorophenyl)ethyl]-2-[(1H-imidazol-1-yl)methyl]-4[((5-trifluoromethylpyridin-2-yl)thio)methyl]-1,3-dioxolane: a novel, inducible binding mode

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Heme oxygenase inhibition by 2-oxy-substituted 1-azolyl-4-phenylbutanes: effect of variation of the azole moiety. X-ray crystal structure of human heme oxygenase-1 in complex with 4-phenyl-1-(1H-1,2,4-triazol-1-yl)-2-butanone

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

A Novel, “Double-Clamp” Binding Mode for Human Heme Oxygenase-1 Inhibition

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Consensus superiority of the pharmacophore-based alignment, over maximum common substructure (MCS): 3D-QSAR studies on carbamates as acetylcholinesterase inhibitors

1 reference

https://api.crossref.org/works/10.1002/CMDC.201800176

7 January 2021

Identifiers

DOI

10.1002/CMDC.201800176

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29693778 AND SRC:MED&resulttype=core&format=json

24 March 2020

1 reference